Tebucur 250EWPlant Protection Product ComparisonPlant Protection Product ComparisonReport inaccuraciesReport inaccuracies

A broad spectrum systemic fungicide for use on cereals and oilseed rape.

Emulsion (oil in water) formulation, containing 250 g/litre (25.8 % w/w) tebuconazole.

DIRECTIONS FOR USE
IMPORTANT: This information is approved as part of the Product Label. All instructions within this section must be read carefully in order to obtain safe and successful use of this product. TEBUCUR 250 EW is recommended for control of a wide range of diseases on winter and spring sown cereals and oilseed rape. For best disease control and yield benefi t TEBUCUR 250 EW should be applied at an early stage of disease development, before infection spreads to new crop growth.

WHEAT, BARLEY, TRITICALE
Diseases: Powdery Mildew, Fusarium Ear blight.
Rate: 1.0 l/ha

OATS, RYE
Diseases: Powdery mildew
Rate: 1.0 l/ha

Critical comments: maximum number of applications - 2. Latest time of application: before grain watery ripe stage (GS 71).

OILSEED RAPE
Diseases: Alternaria, Sclerotinia and phoma leaf spot.
Rate: 1.0 l/ha
Critical comments: maximum number of applications - 2. Latest time of application: before full fl owering (GS 65).

CROP SPECIFIC INFORMATION
WINTER AND SPRING WHEAT, WINTER AND SPRING BARLEY, OATS, TRITICALE AND RYE

Dose rate and application timing
TEBUCUR 250 EW may be applied at any time before the grain milky ripe stage (GS 71).
Maximum individual dose: 1.0 litre per hectare Maximum total dose per crop: 2.0 litres per hectare.

WINTER AND SPRING OILSEED RAPE
TEBUCUR 250 EW may be used on all varieties of winter or spring sown oilseed rape.

Dose rate and application timing
TEBUCUR 250 EW may be applied at any time before full fl owering (GS 65). 1.0 litre per hectare. Maximum individual dose: 1.0 litre per hectare Maximum total dose per crop: 2 litres per hectare.

Diseases Controlled
TEBUCUR 250 EW controls Alternaria, Sclerotinia and phoma leaf spot. It also acts as a growth regulator.

Phoma leaf spot/stem canker
Leaf spot can be found from October onwards and best control of stem canker may be expected from an autumn/early winter application of 500 ml/ha TEBUCUR 250 EW applied at fi rst signs of disease, followed by 500 ml - 1.0 l/ha TEBUCUR 250 EW in late winter/early spring. TEBUCUR 250 EW program applied against phoma leaf spot/stem canker will also give a secondary reduction of oilseed rape growth.
Dark Leaf/Pod Spot (Alternaria spp). Treatment with 1.0 l/ha Folicur 250 EW should begin at the onset of disease.
Sclerotinia Stem Rot. Treatment with 1.0 l/ha TEBUCUR 250 EW should be carried out at early to full fl owering.

MIXING, SPRAYING
Important: Sprayers should be THOROUGHLY CLEANED before use and fi lters and jets checked for damage and blockages.

Mixing
Thoroughly shake the pack before use. Add the required quantity of TEBUCUR 250 EW to the half-fi lled spray tank with the agitation system in operation and then fi ll to the required level. Continue agitation at all times during spraying and stoppages until the tank is completely empty. Spray immediately after mixing. Where tank mixes are used TEBUCUR 250 EW should be added to the spray tank last, after fi rst dispersing the other product(s).

SPRAYING
Apply through conventional crop spraying equipment using a medium quality spray (BCPC) at a pressure of at least 2 bar. Apply in at least 100-400 litres of water per hectare. Boom height and water volume should be adjusted to ensure good coverage of the crop, particularly at later growth stages. In dense crops at later growth stages, higher water volumes should be used as recommended.

RESISTANCE MANAGEMENT
The possible development of diseases resistant to TEBUCUR 250 EW cannot be excluded or predicted. Where such resistant strains occur, TEBUCUR 250 EW is unlikely to give satisfactory control. Repeated application of TEBUCUR 250 EW alone should not be used on the same crop against a high risk pathogen such as cereal powdery mildew. Tank-mixtures or alternation with fungicides having a different mode of action (e.g. morpholines) have been shown to protect against the development of resistant forms of disease.